Showing 3901-3910 of 5646 results for "".
- Lineage Cell Therapeutics Provides Update on OpRegenhttps://modernod.com/news/lineage-cell-therapeutics-provides-update-on-opregen/2481775/Lineage Cell Therapeutics provided an update on its progress with OpRegen (RG6501), its product candidate for patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Lineage stated that it continues to execute its
- Rayner Completes First Implantations of IOLs in Clinical Trials in China and the UShttps://modernod.com/news/rayner-achieves-milestone-implantations-in-clinical-trials-in-china-and-the-us/2481774/Rayner has announced the completion of the first implantations in two pivotal market access studies in the US and China. Rayner's RayOne EMV Toric IOL received investigational device exemption (IDE) approval from the FDA in June. The first study implantation took place at
- Regeneron Presents 2-Year PULSAR Trial Results for Aflibercept 8 MG in Wet AMDhttps://modernod.com/news/regeneron-presents-2-year-pulsar-trial-results-for-aflibercept-8-mg-in-wet-amd/2481772/Regeneron announced positive, 2-year (96 weeks), topline data from the pivotal PULSAR trial investigating aflibercept 8 mg in patients with wet age-related macular degeneration (AMD). During the trial, aflibercept 8 mg patients were initially randomized to either 12- or 16-week dosing interv
- Haag-Streit to Host ‘Eyestar 900 Pearls of Cataract & Refractive Surgery with Swept-Source OCT’ Satellite Symposiumhttps://modernod.com/news/haag-streit-to-host-eyestar-900-pearls-of-cataract-refractive-surgery-with-swept-source-oct-satellite-symposium/2481767/Haag-Streit announced it will host the ‘Eyestar 900 Pearls of Cataract & Refractive Surgery with Swept-Source OCT’ Satellite Symposium at the 41st Congress of the ESCRS in September. Haag-Streit invites delegates to join its distinguished faculty for
- Iveric Bio Receives FDA Approval for Izervay for Geographic Atrophyhttps://modernod.com/news/iveric-bio-receives-fda-approval-for-izervay-for-geographic-atrophy/2481764/Iveric Bio has received FDA approval for Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), parent company Astellas Pharma announced Friday night. Izervay, a new complem
- Oculis’ OCS-01 Eye Drops Studied in LEOPARD Trial to Treat Cystoid Macular Edemahttps://modernod.com/news/oculis-ocs-01-eye-drops-studied-in-leopard-trial-to-treat-cystoid-macular-edema/2481763/Oculis announced that the first patient has been enrolled in the investigator-initiated LEOPARD trial evaluating the potential of OCS-01 eye drops, Oculis’ high-concentration preservative-free topical Optireach formulation of dexamethasone, for the treatment of cystoid macular edema (CME).<
- Bausch + Lomb Announces Changes to its Leadership Teamhttps://modernod.com/news/bausch-lomb-solidifies-leadership-team/2481761/Bausch + Lomb announced changes to its executive leadership team, including the creation of two new roles. This development follows reshuffling announced in early June after chairman and CEO Brent Saunders rejoined B
- Glaucoma Treatment Research at Missouri S&T Receives NIH Fundinghttps://modernod.com/news/glaucoma-treatment-research-at-missouri-st-receives-nih-funding/2481759/The Missouri University of Science and Technology (S&T) announced that the National Institutes for Health (NIH) has awarded an R01 grant to Professor Hu Yang, PhD, who is S&T’s Doshi Endowed Department Chair of Chemical and Biochemical Engineering. The grant will prov
- Skyline Therapeutics’ Gene Therapy Candidate for Wet AMD Receives IND Clearancehttps://modernod.com/news/skyline-therapeutics-gene-therapy-candidate-for-namd-receives-ind-clearance/2481758/Skyline Therapeutics announced that the FDA has cleared the company’s investigational new drug (IND) application for a phase 1/2a clinical trial of SKG0106, a one-time intravitreally delivered adeno-associated virus (AAV) gene therapy for the treatment of wet age-related macular degene
- Vantage Acquires Ophthalmic Surgical Solutionshttps://modernod.com/news/vantage-acquires-ophthalmic-surgical-solutions/2481757/Vantage Surgical Solutions, a provider of mobilized surgical solutions, announced it has acquired Ophthalmic Surgical Solutions (OSS), which specializes in ophthalmic surgical equipment and services. Terms of the deal were not disclosed. According to Vantage, the acquisition c